Presilium Private Wealth, LLC 13F Portfolio

CIK 1939831 Filing since Q4 2022 Q3 2026 filed Oct 26, 2026
Holdings as of Sep 30, 2026, from the 13F filed Oct 26, 2026.

Portfolio Snapshot

49 positions · Q3 2026

Presilium Private Wealth, LLC reported 49 positions worth $34.54M for the quarter ended Sep 30, 2026, up 34.4% on the prior quarter. It opened 14 new positions, added to 30, trimmed 3 and exited 2. Its largest holding is ExxonMobil Holdings Corp at 9.9% of the portfolio.

Portfolio Value
$34.54M
+34.4% QoQ · +72.9% YoY
Positions
49
14 new · 2 sold out
Top 10 Concentration
49%
of portfolio value
Largest Position
XOM 9.9%
ExxonMobil Holdings Corp
Net Buying
+$7.99M
$9.13M bought · $1.14M sold
Turnover
3.8%
of the portfolio traded
Top Sector
Technology
33.3% of value
Track Record
16
quarters on file since Q4 2022

Portfolio Value & Positions

Value Positions

Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.

Sector Allocation

9 sectors
33.28%
Technology
Technology33.28%
Healthcare22.42%
Financial Services11.87%
Energy9.91%
Industrials7.55%
Consumer Staples6.55%
Consumer Discretionary6.31%
Communication Services1.78%
Other0.326%

Quarterly Buying & Selling

Bought Sold

Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.

Position Changes

How many positions were opened, added to, trimmed or closed each quarter.

Sector Allocation Over Time

Share of reported value in each sector at every quarter end.

TechnologyHealthcareFinancial ServicesEnergyIndustrialsConsumer StaplesConsumer DiscretionaryCommunication ServicesOtherUtilities

Largest Buys

Q3 2026
Holding Change Change % Trade Value Weight
MRK Merck & Co., Inc. +7,068 +139.0% $1.03M 5.11%
ABBV AbbVie Inc. +3,243 – $848.25K 2.46%
AVGO Broadcom Inc. +2,231 – $783.50K 2.27%
JPM Jpmorgan Chase & Co +1,946 – $643.88K 1.86%
JNJ Johnson & Johnson +1,856 – $491.41K 1.42%
GLD Spdr Gold Trust +1,177 – $448.25K 1.3%
ABT Abbott Laboratories +3,391 – $335.13K 0.97%
MSFT Microsoft Corp +578 +16.1% $296.45K 6.19%
BRK-B Berkshire Hathaway Inc +575 +92.9% $286.32K 1.72%
BMY Bristol Myers Squibb Co +4,527 +109.4% $282.49K 1.57%

Largest Sells

Q3 2026
Holding Change Change % Trade Value Weight
AZN Astrazeneca Plc -4,342 -100.0% $823.41K Exited
QBTS D-Wave Quantum Inc. -10.6K -100.0% $254.46K Exited
NVS Novartis Ag -300 -6.5% $42.77K 1.78%
IBM International Business Machines Corp -81 -4.2% $17.81K 1.18%
RDY Dr Reddys Laboratories Ltd -8 -0.1% $100.96 0.553%

New Positions

Q3 2026
Holding Shares Trade Value Weight
ABBV AbbVie Inc. +3,243 $848.25K 2.46%
AVGO Broadcom Inc. +2,231 $783.50K 2.27%
JPM Jpmorgan Chase & Co +1,946 $643.88K 1.86%
JNJ Johnson & Johnson +1,856 $491.41K 1.42%
GLD Spdr Gold Trust +1,177 $448.25K 1.3%
ABT Abbott Laboratories +3,391 $335.13K 0.97%
GD General Dynamics Corp +847 $281.06K 0.814%
TSM Taiwan Semiconductor Manufacturing Co Ltd +581 $265.20K 0.768%
TSLA Tesla, Inc. +731 $259.29K 0.751%
PLTR Palantir Technologies Inc. +1,255 $234.84K 0.68%

Closed Positions

Q3 2026
Holding Shares Sold Trade Value Prior Weight
AZN Astrazeneca Plc -4,342 $823.41K 3.2%
QBTS D-Wave Quantum Inc. -10.6K $254.46K 0.99%
Holdings · Q3 2026

49 Positions

As ofSep 30, 2026
Value$34.54M
Top 1049%
Avg position$704.91K
# Activity
34 more holdings Create a free account to keep reading this institution’s full portfolio.
Showing 1–15 of 49 positions 13F filings on SEC EDGAR

Tip. Select a row to see that position’s full history at Presilium Private Wealth.

About Presilium Private Wealth, LLC’s 13F Portfolio

What are Presilium Private Wealth, LLC’s largest holdings?

As of its Q3 2026 13F filing, Presilium Private Wealth, LLC’s five largest positions were ExxonMobil Holdings Corp (XOM) at 9.9%, Apple Inc. (AAPL) at 7.0%, Microsoft Corp (MSFT) at 6.2%, Merck & Co., Inc. (MRK) at 5.1%, Amazon Com Inc (AMZN) at 3.9% of the reported portfolio.

How much is Presilium Private Wealth, LLC’s portfolio worth?

Presilium Private Wealth, LLC reported a 13F portfolio worth $34.54M across 49 positions for Q3 2026. That is up 34.4% from the previous quarter.

What did Presilium Private Wealth, LLC buy in Q3 2026?

Its largest purchases by value were Merck & Co., Inc. ($1.03M), AbbVie Inc. ($848.25K), Broadcom Inc. ($783.50K). It opened 14 new positions.

What did Presilium Private Wealth, LLC sell in Q3 2026?

Its largest sales by value were Astrazeneca Plc ($823.41K), D-Wave Quantum Inc. ($254.46K), Novartis Ag ($42.77K). It exited 2 positions entirely.

Where does this data come from?

From the Form 13F-HR reports Presilium Private Wealth, LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.

Similar-Sized Institutions

by reported 13F value

13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.